Wasatch Micro Cap Fund Q4 2025 Commentary [Seeking Alpha]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Seeking Alpha
Against a volatile market backdrop, the Russell Microcap® Growth Index posted a positive return of 2.14% in the quarter. The 2025 calendar year's low-quality market rally was one of the strongest we've seen in Wasatch's 50-year history. Natali_Mis/iStock via Getty Images Overview Against a volatile market backdrop, the Russell Microcap® Growth Index posted a positive return of 2.14% in the quarter. However, positive contributions to the benchmark's return were dominated by the health- care sector, most notably companies within the biotechnology and pharmaceutical This article was written by Quick Insights Avoiding unprofitable biotech/pharma weighed on relative returns, but strong selection in industrials, consumer staples, and discretionary sectors helped offset this headwind. Axogen benefits from expanded FDA approval and market exclusivity, while Mama's Creations leverages acquisitions and management upgrades for margin expansion and distribution growth. With a f
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know [Yahoo! Finance]Yahoo! Finance
- This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth [Yahoo! Finance]Yahoo! Finance
- AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum [Yahoo! Finance]Yahoo! Finance
- AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]Yahoo! Finance
- AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 2/24/26 - Beat
AXGN
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- 3/2/26 - Form 4
- AXGN's page on the SEC website